Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neuroectodermal Tumors × Vincristine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 119 Precursor Cell Lymphoblastic Leukemia-Lymphoma 91 Lymphoma, Large B-Cell, Diffuse 71 Leukemia 64 Lymphoma, Non-Hodgkin 53 Lymphoma, Follicular 40 Burkitt Lymphoma 39 Lymphoma, Mantle-Cell 35 Hodgkin Disease 27 Central Nervous System Neoplasms 26 Sarcoma 21 Lymphoma, Large-Cell, Immunoblastic 21 Neuroblastoma 19 Multiple Myeloma 15 Lymphoma, Large-Cell, Anaplastic 15 Leukemia, Lymphocytic, Chronic, B-Cell 14 HIV Infections 14 Brain Neoplasms 14 Lymphoma, B-Cell, Marginal Zone 12 Acquired Immunodeficiency Syndrome 11 Rhabdomyosarcoma 10 Medulloblastoma 10 Dendritic Cell Sarcoma, Interdigitating 10 Astrocytoma 10 Neoplasms 9 Oligodendroglioma 8 Lymphoma, B-Cell 8 Neuroectodermal Tumors, Primitive, Peripheral 7 Neoplasms, Plasma Cell 7 Lymphoma, T-Cell 7

Interventions

pralsetinib 1 pembrolizumab 1 pamiparib 1 cixutumumab 1 Vincristine 1 Valproic Acid 1 Radiotherapy 1 Radiation 1 Oncolytic Virotherapy 1 Maintenance Chemotherapy 1 Lomustine 1 Etoposide 1 Cisplatin 1 Antibodies, Monoclonal 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡